
Loading, please wait...

Loading, please wait...

Regular screening mammography detects breast cancer at its most treatable stages, which drastically improves survival outcomes. However, many women experience delayed mammography screening due to socioeconomic barriers or lack of awareness. A recent population-based study from Taiwan suggests that even a two-year delay significantly increases the risk of advanced-stage breast cancer at the time of diagnosis.
The researchers used data from Taiwan's National Health Insurance Research Database to compare early-stage (Stages 0-II) and advanced-stage (Stages III-IV) cases. Specifically, they found that women who never underwent screening had nearly double the odds of receiving an advanced-stage diagnosis (aOR = 1.94). Consequently, the study emphasizes that maintaining a strict screening schedule is essential for early detection.
The study highlights that screening intervals exceeding two years increase the odds of advanced cancer by 42% (aOR = 1.42). If the interval exceeds four years, the risk remains significantly high. Additionally, older women and those in low-income groups showed the highest vulnerability to these delays. Furthermore, the data indicates that age-specific factors play a critical role, as women aged 40-69 saw a pronounced increase in advanced-stage diagnoses when they skipped regular intervals.
Notably, for women in India, these findings carry significant weight. Since national screening uptake remains below 1%, healthcare providers must advocate for consistent screening. Therefore, clinicians should prioritize educating patients about the dangers of postponement. Ultimately, regular screening reduces the need for aggressive treatments and improves the patient\'s quality of life.
Most clinical guidelines, including those from the Breast Imaging Society, India (BISI), recommend annual or biennial mammography for women starting at age 40, depending on individual risk factors.
Breast tumors can grow and spread during the interval between scans. Delaying a mammogram by more than two years increases the likelihood that a tumor will reach an advanced stage (III or IV) before detection.
Research suggests that women over 70 and those from low-income backgrounds are most at risk when they experience delays, often due to reduced access to healthcare and lower screening awareness.
Disclaimer: This content is for informational and educational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
1. Wang YH et al. Delayed mammography screening and advanced breast cancer: variation across age and income groups. BMC Public Health. 2026 May 12. doi: 10.1186/s12889-026-27731-4. PMID: 42121003.
2. Breast Imaging Society, India (BISI). Best Practice Guidelines – Mammography. Available at: bisi.co.in.
3. Indian Council of Medical Research (ICMR). Consensus Document for Management of Breast Cancer. Available at: icmr.gov.in.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Delayed mammography screening (>2 years) significantly increases the odds of advanced breast cancer, particularly in low-income and older age groups....
5 months ago

A multicenter study from Southeastern Türkiye identified rare alpha-1 antitrypsin deficiency variants, including the homozygous Malton genotype, among COPD patients. Half were never-smokers, highlighting the critical need for comprehensive genetic screening beyond common S and Z alleles.
Today

A comprehensive scoping review synthesises evidence linking prenatal maternal mental health to long-term offspring neurodevelopment, evaluating neuroendocrine, inflammatory, and epigenetic pathways while highlighting clinical screening and future research priorities.
Today

The Directorate General of Health Services directs Indian states to halt the hazardous reuse and reprocessing of single-use medical devices. Discover regulatory implications under the Drugs and Cosmetics Act, critical infection risks, legal liabilities, and operational changes required across clinical specialties.
Today

A 25-year multi-institutional cohort reveals high recurrence rates in pediatric giant cell tumor of bone, particularly in patients with open physes and bone marrow edema on preoperative MRI. Early surveillance and careful balance between growth plate preservation and tumor clearance are essential.
Today

India is advancing preventive healthcare by integrating genomics, artificial intelligence, and quantum technologies. With the SANGAM programme sequencing one million Indian genomes, clinicians can unlock personalized therapies, detect cardiometabolic risks early, and curb the burden of diabetes and heart disease.
Today